GLMD — Galmed Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $1.75m
- -$9.06m
- 29
- 58
- 23
- 29
Annual cashflow statement for Galmed Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -20.5 | -28.8 | -32.5 | -17.9 | -6.91 |
| Depreciation | |||||
| Non-Cash Items | 2.05 | 1.34 | 1.98 | 1.78 | 0.612 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 3.44 | 1.1 | -2.45 | -2.45 | 0.132 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -14.9 | -26.3 | -32.9 | -18.5 | -6.14 |
| Capital Expenditures | -0.012 | -0.044 | -0.011 | -0.004 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 6.69 | 16.6 | 11.5 | 17.6 | 0.8 |
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 6.68 | 16.5 | 11.5 | 17.6 | 0.8 |
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 0.143 | 0.768 | 17.4 | 0.07 | 6.18 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -8.12 | -8.98 | -4.06 | -0.868 | 0.848 |